CIHR Innovation and Industry Programs
In partnership with
The Canadian Association for the Study of the Liver
| Important Dates | |
| Opportunity Launched | June 2006 |
| Content Last Updated | October 24, 2006 (Important Dates) |
| November 6, 2006 | Full applications must be courier stamped by this date. (Updated: 2006-10-24) |
| November 30, 2006 | Relevancy review will be completed by this date. |
| December 31, 2006 | Peer Review will be completed by this date. |
| January 31, 2007 | Anticipated notification of decision. |
| June 1, 2007 | Earliest start date. |
| Additional Information | Applicants must choose the most appropriate CIHR peer reviewed research training award program for which they are eligible and may only submit an application to one of these programs. Applicants must wait until after they are notified of the decision for one application before they can submit to another training award opportunity. |
| Funds Available | |
| CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them. The maximum amount awarded for a single award is $60,000 for up to 2 years:
| |
| Summary | |
| The purpose of this Request for Applications is to build, in collaboration with industry, Canadian capacity and expertise in the area of hepatology. It is expected that this targeted investment will promote excellence in research through training awards. | |
Background
Partners
Objectives
Eligibility
Allowable Costs
Review Process and Evaluation Criteria
General CIHR Guidelines
Conditions of Funding
Communications Requirements
Monitoring, Performance Measurement and Evaluation
How to Apply
Contact Information
Description of Partners
The Canadian Association for the Study of the Liver (CASL) in association with Canadian Institutes of Health Research (CIHR) and our industrial partners (Astellas Pharma Canada Inc., Axcan Pharma, Schering Canada, Hoffmann-La Roche) have established fellowships to support clinical or basic research in hepatology in Canada.
CIHR's Innovation and Industry Programs are dedicated to identifying and developing collaborations with other CIHR institute(s), branch(es) or office(s), funding organizations and stakeholders to enhance the availability of funding for this strategic initiative, and to create, where appropriate, opportunities for knowledge exchange and translation related to the scope of this particular initiative. Applicants are invited to visit the Descriptions of Partners to find a list of partners and their respective mandates and/or strategic interests. This list will continue to evolve as new partners join in this initiative. The specific research foci and requirements for each partner are outlined in the section "Objectives."
The specific objective of this initiative is to build, in collaboration with industry, Canadian capacity and expertise in the area of hepatology. It is expected that this targeted investment will promote excellence in research through training awards and will provide either clinical or basic research training in hepatology. For some candidates, it may serve as a bridge to additional research training.
In addition, the intent of this initiative is to facilitate the translational objectives of CIHR, with particular interests in clinical research. Clinical research combines discoveries from the basic science laboratory incorporating the observations and insights of health professionals (a key aspect of translational research). It is the creation of new health knowledge and the translation of that knowledge from the research setting into applications where it ultimately impacts on the health of Canadians.
Relevant Research Areas
Relevant research areas include:
CASL and CIHR will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described above.
Upon completion of peer review, CASL will receive the ranking list, merit scores (ratings) and recommendations of the peer review committee with regards to funding level and award term, for the submitted applications that fall in the fundable range and have been determined to be relevant to the specific research areas and objectives of the initiative. The list will be used for funding decision-making purposes and will remain anonymous.
The review of applications for relevance to the strategic initiative will have no impact on the peer review process.
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Specific to CIHR industry-partnered programs, please refer to the General Guidelines for Industry-Partnered Programs.
Specific to CIHR training awards, please refer to the General Guidelines for Training Programs.
Specific Eligibility Requirements
Eligibility requirements specific to this Request for Applications include the following:
The awards consist of a stipend and a research allowance.
For the research allowance, awardees should review the Tri-Agency (CIHR, NSERC and SSHRC) financial administration guidelines, Use of Grant Funds section for a complete listing and description of allowable costs and activities.
A CIHR peer review committee will evaluate the full applications. Committee members are selected based on suggestions from many sources including the institute(s) / portfolio(s) and partner(s), following CIHR's Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP). Fellowship Awards are reviewed in accordance with the Guide for Reviewer - CIHR Fellowships.
The following general criteria for evaluating Fellowship Award applications will be used:
This Request for Applications will follow the CIHR General Grants and Awards Policies. Applicants are encouraged to demonstrate the use of gender and sex-based analysis in applications.
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Request for Application. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.
In addition to CIHR standard guidelines and requirements, the following special conditions shall apply:
The award must be initiated within a maximum two (2) years following completion of the candidates specialty or subspecialty training. During the tenure of the fellowship, fellows are not permitted to hold a second major award. In general, it is recommended that these Fellowships be carried out at Canadian Centres unless it can be shown that no equivalent training is available in Canada. For training in Canada, the supervisor has to be a member of the Canadian Association for the Study of the Liver.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this Request for Applications and all matters pertaining thereto.
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Request for Applications will be collected, used and disclosed in compliance with the PIPEDA.
Award recipients are required to acknowledge CIHR, its institutes and partners in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Acknowledgement of CIHR's Support for details on CIHR's communication requirements. The contributing institutes / partners will be identified on the Authorization for Funding and decision letter.
CIHR is committed to demonstrating results to Canadians for the money invested in health research. Therefore, processes for monitoring progress and appropriate use of funds, as well as for performance measurement and program evaluation are in place. As a result, funding recipients must:
The application process is comprised of one step: Submission of Full Application.
Review the application instructions provided in How to Apply for Funding.
Select "Fellowships - Industry-partnered - Application" from the Training Programs Application Packages.
Additional instructions must be followed for this RFA.
Send the completed application package (1 original plus 2 copies) by courier to:
RE: "CASL/CIHR Innovation and Industry Hepatology Fellowship Program"
Research Translation Programs Branch
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address locator: 4809A
Ottawa, Ontario K1A 0W9
(Updated: 2006-06-21)
In addition, send five (5) copies of the completed application package by courier to:
c/o Ms. Reanne Belisle
CASL Main Office
34 Eglinton Avenue West
Suite 323
Toronto, ON M4R 2H6
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Jacqueline Jorge
Program Delivery Officer
Innovation and Industry Programs
Canadian Institutes of Health Research
Telephone: (613) 952-5728
Fax: (613) 954-1800
Email: jjorge@cihr-irsc.gc.ca
For questions about this initiative and research objectives contact:
Dr. Winnie Wong
Chair, Education Committee
Canadian Association for Study of Liver (CASL)
34 Eglinton Avenue West, Suite 323
Toronto, ON M4R 2H6
Tel: (416) 847-0053
Fax: (416) 847-0054
Email: casl@hepatology.ca
Canadian Institutes of Health Research (CIHR)
CIHR is Canada's major federal funding agency for health research. Its objective is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system. CIHR's Innovation and Industry Programs are designed to help the academic community interact with Canadian companies with an interest in health research and development. The programs promote a wide variety of peer-review research and training projects jointly funded by Canadian companies and CIHR. The research planned should be beneficial to both parties, while improving the quality of health of Canadians.
CIHR/Rx&D Collaborative Research Program enables scientists, clinicians and members of the full spectrum of health professions, and Rx&D members to optimize opportunities in clinical research intended to ultimately impact on the health of Canadians.
The CIHR/Small & Medium Enterprise (SME) Research Program, implemented in 2000, is designed to help the academic community interact with Canadian SMEs with an interest in health research and development. The program promotes a wide variety of peer-reviewed research and training projects jointly funded by Canadian SMEs and CIHR. The research planned should be beneficial to both parties, while improving the quality of health of Canadians.
Partners
Canadian Association for the Study of the Liver (CASL)
The Canadian Association for the Study of the Liver represents a multidisciplinary group of doctors, scientists and health care providers whose expertise focuses on the liver. CASL is committed to providing national leadership in all aspects of research, teaching and patient care as it pertains to the liver. Our goals are to improve the quality of health care; support education; promote research and provide a forum for research dialogue; and enhance our role as a world leader in hepatology. These goals are achieved by developing partnerships with groups including research agencies, charitable organizations, universities, governments, industry, regulatory bodies, allied health care workers, and the public.
